Figure 2
Guidance for symptomatic patients in clinical practice. CA, catheter ablation; ECG, electrocardiogram; ELR, external loop recorder; EPS, electrophysiology study; ICM, implantable cardiac monitor; PER, post-event recorder; SHD, structural heart disease. * If syncope during or shortly after exertion, left ventricular hypertrophy suggesting cardiomyopathy, ECG changes consistent with acute ischaemia, pre-excited QRS complexes; ** If syncope and bundle branch block in resting ECG, pre-excited QRS complexes, paroxysmal supraventricular tachycardia; *** Provocative test with ajmaline/flecainide when Brugada syndrome is suspected, cardiac magnetic resonance when arrhythmogenic ventricular cardiomyopathy is suspected.

Guidance for symptomatic patients in clinical practice. CA, catheter ablation; ECG, electrocardiogram; ELR, external loop recorder; EPS, electrophysiology study; ICM, implantable cardiac monitor; PER, post-event recorder; SHD, structural heart disease. * If syncope during or shortly after exertion, left ventricular hypertrophy suggesting cardiomyopathy, ECG changes consistent with acute ischaemia, pre-excited QRS complexes; ** If syncope and bundle branch block in resting ECG, pre-excited QRS complexes, paroxysmal supraventricular tachycardia; *** Provocative test with ajmaline/flecainide when Brugada syndrome is suspected, cardiac magnetic resonance when arrhythmogenic ventricular cardiomyopathy is suspected.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close